Progeria treatment research, micrographs

Progeria treatment research, micrographs

C022/8313 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 25.0MB

Downloadable file size: 4.1MB

Price image Pricing

Please login to use the price calculator


Caption: Progeria treatment research. Fluorescent light micrographs showing the blood vessel of an untreated mouse with progeria (left) compared to the blood vessel of a similar mouse treated with the farnsyltransferase inhibitor drug tipifarnib (right). Progeria is a rare genetic disorder that causes a person's body to age at a very early age. Here, tipifarnib has blocked the loss of smooth muscle cells (stained green) in blood vessels, preventing the cardiovascular disease characteristic of progeria.

Release details: Model release not required. Property release not required.

Keywords: abnormal, animal testing, biochemical, biochemistry, biological, biology, blood vessel, cardiovascular disease, circulatory system, compared, comparing, comparison, condition, disease, diseased, disorder, drug, farnsyltransferase, fluorescence, fluorescent, genetic, healthy, inhibitor, micrograph, microscope, mouse, no-one, nobody, normal, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, photomicrograph, progeria, research, rodent, test, treated, treatment, unhealthy, untreated, vascular, vessels

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.